Arch Oncology ended its work on developing an anti-CD47 antibody and most employees have left the company, Endpoints News has learned. The Brisbane, CA,...
Arch Oncology ended its work on developing an anti-CD47 antibody and most employees have left the company, Endpoints News has learned. The Brisbane, CA,...
Innofiber appoints CEO with track record of growing B2B medical device and industrials businesses Innofiber, a leading supplier and manufacturer of fiber...
Sanofi Ventures – focused on early-to-mid stage investing, company co-creation, leading financing rounds, and prioritising those companies advancing The...
Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, The post JPM2023: Breakthroughs await, but...
Investors Alley The Viral “Tripledemic” Opportunity Scientists began warning of a potential “twindemic” – a simultaneous surge in both Covid-19...
New company advances precision health through data-driven solutions New company Velsera was announced at the J.P. Morgan Healthcare Conference in San Francisco,...
Vijay Kedar, Co-Founder and CEO at Tomorrow Health Health systems will realize their challenges are not transitory but systemic: This year saw health systems...
d’Artagnan Osborne, GM of Payment Solutions at Kareo, a Tebra Company Staffing shortages, cost of care delivery and reimbursement changes have put more...
A next-generation sequencing (NGS) novice planning to buy a sequencing instrument might expect to hear a used-car-style sales pitch: “You want short...